Guardion Health Sciences, Inc.
GHSI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.43 | 0.01 | 0.01 | -0.01 |
| FCF Yield | -64.45% | -91.57% | -69.94% | -136.14% |
| EV / EBITDA | -0.11 | 0.41 | -1.16 | 0.26 |
| Quality | ||||
| ROIC | -40.91% | 4.96% | -48.19% | -93.92% |
| Gross Margin | 44.04% | 40.91% | 43.00% | -3.01% |
| Cash Conversion Ratio | -27.65 | 0.50 | 0.43 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | 19.19% | 80.15% | 100.09% | 26.12% |
| Free Cash Flow Growth | 41.31% | 30.48% | -33.08% | -29.89% |
| Safety | ||||
| Net Debt / EBITDA | 1.62 | 1.75 | 0.42 | 0.97 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -1,176.14 |
| Efficiency | ||||
| Inventory Turnover | 2.56 | 2.09 | 11.21 | 5.06 |
| Cash Conversion Cycle | 177.64 | 153.08 | 82.42 | -39.70 |